Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Jaime Natan EISIG"'
Autor:
Fernando Marcuz Silva, Elaine Cristina Silveira de Queiroz, Tomás Navarro-Rodriguez, Ricardo Correa Barbuti, Rejane Mattar, Kiyoshi Iriya, Jin Hwa Lee, Jaime Natan Eisig
Publikováno v:
Clinics, Vol 70, Iss 5, Pp 318-321 (2015)
OBJECTIVES: The eradication of Helicobacter (H.) pylori allows peptic ulcers in patients infected with the bacteria to be cured. Treatment with the classic triple regimen (proton pump inhibitor, amoxicillin and clarithromycin) has shown decreased eff
Externí odkaz:
https://doaj.org/article/8456ba9a3dfe4faa825cb859ceb2af16
Autor:
Antonio Moreira MENDES-FILHO, Joaquim Prado Pinto MORAES-FILHO, Ary NASI, Jaime Natan EISIG, Tomas Navarro RODRIGUES, Ricardo Correa BARBUTTI, Josemberg Marins CAMPOS, Décio CHINZON
Publikováno v:
ABCD: Arquivos Brasileiros de Cirurgia Digestiva, Vol 27, Iss 1, Pp 3-8 (2014)
Background : Gastroesophageal reflux disease is a worldwide prevalent condition that exhibits a large variety of signs and symptoms of esophageal or extra-esophageal nature and can be related to the esophagic adenocarcinoma. In the last few years, gr
Externí odkaz:
https://doaj.org/article/c36f2d884e26437baefebb40886a745a
Autor:
Jaime Natan Eisig, Fernando Marcuz Silva, Ricardo Correa Barbuti, Tomás Navarro-Rodriguez, Joaquim Prado P Moraes-Filho, José Pedrazzoli Jr
Publikováno v:
Arquivos de Gastroenterologia, Vol 48, Iss 4, Pp 261-264 (2011)
CONTEXT: The antibiotic susceptibility is the cornerstone for the eradication therapies of Helicobacter pylori. OBJECTIVES: To evaluate the prevalence of primary resistance of H. pylori was evaluated in an urban Brazilian population. METHODS:H. pylor
Externí odkaz:
https://doaj.org/article/dd0f0729d7054e2993515aed8d9e748e
Autor:
Claudia Cristina de Sá, Humberto Setsuo Kishi, Ana Luiza Silva-Werneck, Joaquim Prado Pinto de Moraes-Filho, Jaime Natan Eisig, Ricardo Correa Barbuti, Claudio Lyioti Hashimoto, Tomas Navarro-Rodriguez
Publikováno v:
Clinics, Vol 66, Iss 4, Pp 557-561 (2011)
BACKGROUND: TREATMEN The contribution of eosinophilic esophagitis (EoE) to refractory gastroesophageal reflux disease (GERD) remains unknown. When EoE and GERD overlap, the clinical, endoscopic and histological findings are nonspecific and cannot be
Externí odkaz:
https://doaj.org/article/75e4e89f98e742f2a884447ff5a91971
Autor:
Carlos Alexandre Gonçalves Batista, Fernando Marcuz Silva, Ricardo Correa Barbuti, Jaime Natan Eisig, Rejane Mattar, Tomás Navarro-Rodriguez
Publikováno v:
Arquivos de Gastroenterologia, Vol 46, Iss 3, Pp 204-208 (2009)
CONTEXT: Whether Helicobacter pylori infection is a protective or predisposing factor for the development of gastroesophageal reflux disease remains controversial. The most virulent strains, such as those expressing the cytotoxin-associated gene A (C
Externí odkaz:
https://doaj.org/article/f03d8ab327774af9a781d5531701ee49
Autor:
Jaime Natan Eisig, Tomás Navarro-Rodriguez, Ana Cristina Sá Teixeira, Fernando Marcuz Silva, Rejane Mattar, Decio Chinzon, Christiane Haro, Márcio Augusto Diniz, Joaquim Prado Moraes-Filho, Ronnie Fass, Ricardo Correa Barbuti
Publikováno v:
Gastroenterology Research and Practice, Vol 2015 (2015)
Aim. To compare 10-day standard triple therapy versus sequential therapy as first-line treatment in patients infected with H. pylori. Methods. One hundred H. pylori positive patients (diagnosed by rapid urease test and histology), with average age of
Externí odkaz:
https://doaj.org/article/50d152e6f55f489a9a316cda381a867b
Autor:
Jaime Natan Eisig, Fernando Marcuz Silva, Tomás Navarro Rodriguez, Cláudio Lyoti Hashimoto, Ricardo Correa Barbuti
Publikováno v:
Clinics, Vol 60, Iss 6, Pp 485-488 (2005)
PURPOSE: Many of the currently used eradication regimens against Helicobacter pylori fail to cure the infection either due to antimicrobial resistance or to poor patient compliance. The infection leads to increased risk of developing potentially seve
Externí odkaz:
https://doaj.org/article/f482f762353d4da2b65dd947500adc3b
Autor:
Joaquim Prado P. Moraes-Filho, Décio Chinzon, Jaime Natan Eisig, Claudio L. Hashimoto, Schlioma Zaterka
Publikováno v:
Arquivos de Gastroenterologia, Vol 42, Iss 2, Pp 122-127 (2005)
BACKGROUND: The epidemiological aspects of heartburn and gastroesophageal reflux disease have been object of growing interest in the last decade because of its increasing prevalence and the complications of the disease. AIMS: To evaluate the prevalen
Externí odkaz:
https://doaj.org/article/0b2247b224f3436fb9f6c5f8afb443dd
Autor:
Edson Pedro da Silva, Farid Nader, Flavio A. Quilici, Jaime Natan Eisig, Schlioma Zaterka, Ulysses Meneghelli
Publikováno v:
Arquivos de Gastroenterologia, Vol 40, Iss 4, Pp 262-267 (2003)
BACKGROUND: Esomeprazole, an S-isomer of omeprazole, is the first proton pump inhibitor developed as an optical isomer, and it has shown high healing rates in erosive esophagitis. AIM: To evaluate the efficacy and tolerability of esomeprazole in subj
Externí odkaz:
https://doaj.org/article/476f5467cd4942d987c7383bb00da6df
Autor:
Jaime Natan Eisig, Suraia Boaventura André, Fernando Marcuz Silva, Cláudio Hashimoto, Joaquim Prado Pinto Moraes-Filho, Antonio Atilio Laudanna
Publikováno v:
Arquivos de Gastroenterologia, Vol 40, Iss 1, Pp 55-60 (2003)
BACKGROUND: Many of the currently used Helicobacter pylori eradication regimens fail to cure the infection due to either antimicrobial resistance or poor patient compliance. Those patients will remain at risk of developing potentially severe complica
Externí odkaz:
https://doaj.org/article/2d2c10541c384981943c6eae3354ecae